Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)

Fig. 3

Mean Hb changes for the IIM prospective phases versus the IS retrospective phase. Non-inferiority was achieved for the primary endpoint comparison of IIM 0–3 months to IS where the lower limit of the 95% CI was above the margin of − 0.15 g/dL. CI = confidence interval; Hb = haemoglobin; IIM = iron isomaltoside; IS = iron sucrose

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us